Jun Ki Hong

Government of the Republic of Korea — South Korea

Medicine · Health Sciences

10h-index1.4kcitations59works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(25), Cytokine Signaling Pathways and Interactions(24), interferon and immune responses(16), Ferroptosis and cancer prognosis(8), Hepatitis B Virus Studies(5)

Publications59 total

Supplementary Table 2 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Table 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Table 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 5 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 7 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 7 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 3 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Data from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 3 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 2 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 4 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 8 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Table 2 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 4 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 6 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Data from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 9 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 5 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
page 1 of 3Next →

Frequent Co-authors

Dong‐Hoon Jin(28), Dong‐In Koh(27), Joseph Kim(25), Yoon Sun Park(25), Yea Seong Ryu(25), Jae-Sik Shin(21), Minki Lee(21), Mi So Lee(21), Jun Hyung Lee(21), Seunggeon Bae(21), Mingee Choi(21), Hong-Rae Jeong(20), Seung-Woo Hong(20), Dong Kwan Kim(20), Hyun-Kyung Lee(20), Bomi Kim(20), Yoo Sang Yoon(20), Seungwoo Hong(8), Jai-Hee Moon(7), Jae-Sik Shin(7)